1. Bodenheimer T (2000) Uneasy alliance – clinical investigators and the pharmaceutical industry. N Engl J Med 342(20):1539–1544
2. Caldwell PHY, Murphy SB, Butow PN, Craig JC (2004) Clinical trials in children. Lancet 364:803–811
3. Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391(10128):1357–1366. https://doi.org/10.1016/S0140-6736(17)32802-7
4. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, Knoeppel C, Seyberth H, Pandolfini C, Raffaelli MP, Rocchi F, Bonati M, Jong G, de Hoog M, van den Anker J (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. Eur Netw Drug Investig Child Br Med J 320:79–82
5. David JP, Gaul D (2009) Forschungsförderung in Europa – eine Erfolgsgeschichte. Entwicklung und Funktion der Forschungsrahmenprogramme der Europäischen Union. Wissenschaftsmanagement 6:20–25